Pharmacology of moxonidine:: An I1-imidazoline receptor agonist

被引：36
|
作者：
Ernsberger, P [1 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Div Hypertens, Dept Nutr, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Med Hypertens, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Sch Med, Dept Pharmacol & Neurosci, Cleveland, OH 44106 USA
来源：
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 2000年 / 35卷
关键词：
imidazoline receptor; moxonidine; radioligand binding; PC12 pheochromocytoma cells; rats;
D O I：
10.1097/00005344-200000004-00005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The I-1-imidazoline receptor is a novel neurotransmitter receptor found mainly in the brainstem, adrenal medulla and kidney. The actions of moxonidine are described at the level of individual biomolecules, cells, tissues, organs and finally with integrative functions. The receptor functions at the cellular level works through arachidonic acid and phospholipid signaling cascades in neuronal cells with the net result of inhibiting sympathetic premotor neurons.
引用
收藏
页码：S27 / S41
页数：15
相关论文
共 50 条
  • [41] Clinical assessment of prolonged therapy of patients with hypertension and diabetes with imidazoline receptor agonist moxonidine
    Trusov, VV
    Aksenov, KV
    Filimonov, MA
    KARDIOLOGIYA, 2002, 42 (02) : 50 - 53
  • [42] Effect of imidazoline receptor agonist moxonidine and femoston on the hemodynamic parameters in postmenopausal women with hypertension
    Dadashova, G. M.
    Bakhshaliyev, A. B.
    JOURNAL OF HYPERTENSION, 2006, 24 : S355 - S355
  • [43] α2A-adrenoceptors, not I1-imidazoline receptors, mediate the hypotensive effects of rilmenidine and moxonidine in conscious mice -: In vivo and in vitro studies
    Zhu, QM
    Lesnick, JD
    Jasper, JR
    MacLennan, SJ
    Dillon, MP
    Eglen, RM
    Blue, DR
    IMIDAZOLINE RECEPTORS AND THEIR ENDOGENOUS LIGANDS: CURRENT CONCEPTS AND THERAPEUTIC POTENTIAL, 1999, 881 : 287 - 289
  • [44] Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
    Tishina, E. V.
    Mychka, V. B.
    Zhernakova, Yu. V.
    Ivanov, K. P.
    Tolstov, S. N.
    Chazova, I. E.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2011, 10 (03): : 40 - 46
  • [45] Selective imidazoline agonist moxonidine in obese hypertensive patients
    Sanjuliani, AF
    De Abreu, VG
    Francischetti, EA
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (05) : 621 - 629
  • [46] Does IRAS-1 encode the I1-imidazoline receptor?: Effects of IRAS-1 antisense
    Sun, Z
    Chang, CH
    Ernsberger, P
    FASEB JOURNAL, 2004, 18 (04): : A223 - A223
  • [47] VASODEPRESSION ELICITED IN HYPERTENSIVE RATS BY THE SELECTIVE I(1)-IMIDAZOLINE AGONIST MOXONIDINE ADMINISTERED INTO THE ROSTRAL VENTROLATERAL MEDULLA
    HAXHIU, MA
    DRESHAJ, I
    EROKWU, B
    SCHAFER, SG
    CHRISTEN, MO
    ERNSBERGER, PR
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 : S11 - S15
  • [48] Rilmenidine extends lifespan and healthspan in Caenorhabditis elegans via a nischarin I1-imidazoline receptor
    Bennett, Dominic F.
    Goyala, Anita
    Statzer, Cyril
    Beckett, Charles W.
    Tyshkovskiy, Alexander
    Gladyshev, Vadim N.
    Ewald, Collin Y.
    de Magalhaes, Joao Pedro
    AGING CELL, 2023, 22 (02)
  • [49] ANTIHYPERTENSIVE THERAPY WITH MOXONIDINE - HIGH ACCEPTANCE OF THE IMIDAZOLINE RECEPTOR AGONIST IN A LARGE-SCALE TRIAL
    LOWKROGER, A
    ROSENTHAL, J
    HERZ KREISLAUF, 1994, 26 (06): : 206 - 210
  • [50] Moxonidine, a selective α2-adrenergic and imidazoline receptor agonist, produces spinal antinociception in mice
    Fairbanks, CA
    Wilcox, GL
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 290 (01): : 403 - 412
12345